Daesung Microbiological Labs

대성미생물 · 036480

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$18.1M (₩25B)

Overview

Daesung Microbiological Labs makes microbiological and related health-care products, biological preparations used in medical, veterinary, or laboratory settings.

It supplies these products to customers in the health-care sector and is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. The company has consolidated subsidiaries, indicating it operates as a group with more than one business entity.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$18.8M

▲ +9.2% YoY

Operating profit · FY2025

−US$274.9K

Loss widened

Net income · FY2025

−US$274.9K

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$18.5M(₩25.6B)	US$17.2M(₩23.8B)	US$18.8M(₩26B)
Operating profit	−US$499.3K(−₩689M)	−US$14K(−₩19.3M)	−US$274.9K(−₩379.3M)
Net income	−US$783.9K(−₩1.1B)	−US$14K(−₩19.3M)	−US$274.9K(−₩379.3M)

Revenue

FY2023US$18.5M
FY2024US$17.2M
FY2025US$18.8M

Operating profit

FY2023−US$499.3K
FY2024−US$14K
FY2025−US$274.9K

Net income

FY2023−US$783.9K
FY2024−US$14K
FY2025−US$274.9K

Key ratios (FY2025)

ROE

-1.1%

Debt/Eq

63.7%

Op. margin

-1.5%

Net margin

-1.5%

Rev. YoY

▲ +9.2%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?